Table 6.

Logistic regression analysis of macrophage infiltration

	Analysis
	Single		Multiple
	OR (95% CI)	p-value	OR (95% CI)	p-value
Age (years)	3.23 (0.93–11.3)	0.066
Male	1.26 (0.43–3.69)	0.672
Body mass index	0.48 (0.15–1.53)	0.215
Diabetes mellitus	1.04 (0.37–2.95)	0.940
Hypertension	1.14 (0.42–3.09)	0.804
Dyslipidemia	0.46 (0.13–1.67)	0.237
Chronic kidney disease	1.11 (0.36–3.41)	0.858
Current smoker	1.75 (0.62–4.94)	0.290
Obstructive sleep apnea	2.08 (0.72–6.05)	0.177
Apnea hypopnea index	7.80(1.61–37.9)	0.011	5.97 (1.10–32.5)	0.039
Family history of coronary artery disease	2.18 (0.52–9.25)	0.289
History of PCI or CABG	0.32 (0.12–0.85)	0.023
History of myocardial infarction	0.38 (0.13–1.12)	0.078
Prior statin use	0.20 (0.07–0.58)	0.003	0.23 (0.07–0.73)	0.012
Prior aspirin use	0.19 (0.07–0.52)	0.001
Prior clopidogrel use	0.27 (0.09–0.84)	0.024
Prior ACEI or ARB	0.79 (0.28–2.22)	0.649
Prior calcium channel blocker use	0.68 (0.24–1.90)	0.465
Prior beta blocker use	0.45 (0.16–1.27)	0.132
Prior eicosapentaenoic acid	0.60 (0.12–2.91)	0.526
Prior ezetimibe	1.29 (0.20–8.21)	0.791
Hemoglobin (g/dl)	2.25 (0.78–6.49)	0.133
HbA1c (%)	3.39 (0.65–17.6)	0.147
Glucose (mg/dl)	3.00 (1.08–8.34)	0.035	2.95 (0.93–9.39)	0.066
LDL-C (mg/dl)	2.32 (0.77–6.95)	0.133
Triglyceride (mg/dl)	0.41 (0.15–1.08)	0.071
HDL-C (mg/dl)	0.60 (0.22–1.64)	0.317
LDL-C to HDL-C ratio	1.93 (0.69–5.44)	0.212
Acute coronary syndrome	1.33 (0.51–3.48)	0.557
ST-elevation myocardial infarction	0.77 (0.29–2.07)	0.603
Non ST-elevation myocardial infarction	2.00 (0.65–6.13)	0.225

OR odds ratio, CI confidence interval, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, TIA transient ischemic attack, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker